Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Taper Duration and Naltrexone Incentives in Opioid-Dependent Youth
NCT00182572Phase 2Unknown
- Sponsor
- National Development and Research Institutes
- Start
- Jul 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine, naltrexone in opioid use disorder (OUD), sponsored by National Development and Research Institutes. Status: unknown.
02
Drugs
buprenorphinenaltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00182572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182572.